Tandem Diabetes Care (TNDM) in Pivotal Point Check: 58% Margin Record After Strategic Model Shift and Sales Through Pharmacy Channel!
Reading Time: 3 minutes
Q4 Results Exceed Expectations: Revenue rises by 15% to $290.4 million. Strategic Shift: Transition to the "Pay-as-you-go" pharmacy model secures higher margins in the long term. Mobi Pump as a Growth Driver: Strong demand for the world's smallest insulin pump boosts global shipments. Tandem Diabetes Care is a medical technology company specializing in the development and distribution of innovative insulin pump systems for people with diabetes. The core of the portfolio is the t:slim X2 platform with Control-IQ technology...
Read this article now with a free account.
Your benefits:
- Every month, you can read 5 articles from the premium section for free.
- Monthly 2 trial issues of the Trader newspaper for free.
- Create a personal watchlist with an overview of news about your stock.
